Skip to main content
Top
Published in: Archives of Virology 7/2012

Open Access 01-07-2012 | Brief Report

Inhibition of HSV-1 by chemoattracted neutrophils: supernatants of corneal epithelial cells (HCE) and macrophages (THP-1) treated with virus components chemoattract neutrophils (PMN), and supernatants of PMN treated with these conditioned media inhibit viral growth

Authors: Kozaburo Hayashi, Laura C. Hooper, Toshiomi Okuno, Yuichiro Takada, John J. Hooks

Published in: Archives of Virology | Issue 7/2012

Login to get access

Abstract

The role of PMNs (neutrophils) in corneal herpes was studied using an in vitro system. Human corneal cells (HCE) and macrophages (THP-1) infected with HSV-1 or treated with virus components (DNA or virus immune complexes) released chemokines, which attracted PMNs. Highly reactive oxygen species were detected in PMNs. PMNs inhibited HSV when overlaid onto infected HCE cells (50:1). PMNs incubated with the supernatants of HCE cells treated with virus components released H2O2 and myeloperoxidase. These inhibited virus growth. PMNs released NO and MIG, which may differentiate CD4 T cells to Th1. PMNs participate in innate immune responses, limit virus growth, and initiate immunopathology.
Literature
1.
go back to reference Biswas PS, Rouse BT (2005) Early events in HSV keratitis setting the stage for a blinding disease. Microb Infect 7:799–810CrossRef Biswas PS, Rouse BT (2005) Early events in HSV keratitis setting the stage for a blinding disease. Microb Infect 7:799–810CrossRef
2.
go back to reference Biswas PS, Benerjee K, Kinchington PR, Rouse BT (2006) Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res 82:46–54PubMedCrossRef Biswas PS, Benerjee K, Kinchington PR, Rouse BT (2006) Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res 82:46–54PubMedCrossRef
3.
go back to reference Deshpande S, Banerjee K, Biswas PS, Rouse BT (2004) Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Rev Mol Med 2004:1–14 Deshpande S, Banerjee K, Biswas PS, Rouse BT (2004) Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Rev Mol Med 2004:1–14
4.
go back to reference Thomas J, Gangarpa S, Kanangat S, Rouse BT (1997) On the essential involvement of neutrophils in the immunopathogenic disease: herpes stromal keratitis. J Immunol 158:1383–1391PubMed Thomas J, Gangarpa S, Kanangat S, Rouse BT (1997) On the essential involvement of neutrophils in the immunopathogenic disease: herpes stromal keratitis. J Immunol 158:1383–1391PubMed
5.
go back to reference Tumpey TM, Chen SH, Oakes R, Lausch N (1996) Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol 70:898–904PubMed Tumpey TM, Chen SH, Oakes R, Lausch N (1996) Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol 70:898–904PubMed
6.
go back to reference Shimomura Y, Deai T, Fukuda M, Higaki S, Hooper LC, Hayashi K (2007) Corneal buttons obtained from HSK patients harbor high copy number of the HSV genome. Cornea 26:190–193PubMedCrossRef Shimomura Y, Deai T, Fukuda M, Higaki S, Hooper LC, Hayashi K (2007) Corneal buttons obtained from HSK patients harbor high copy number of the HSV genome. Cornea 26:190–193PubMedCrossRef
7.
go back to reference Hayashi K, Hooper LC et al (2006) Herpes simplex virus 1 (HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors. J Gen Virol 87:2161–2169PubMedCrossRef Hayashi K, Hooper LC et al (2006) Herpes simplex virus 1 (HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors. J Gen Virol 87:2161–2169PubMedCrossRef
8.
go back to reference Hayashi K, Hooper LC, Detrick B, Hooks JJ (2009) HSV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9. Arch Virol 154:219–226PubMedCrossRef Hayashi K, Hooper LC, Detrick B, Hooks JJ (2009) HSV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9. Arch Virol 154:219–226PubMedCrossRef
9.
go back to reference Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T (2003) Development of new fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 278:3170–3175PubMedCrossRef Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T (2003) Development of new fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 278:3170–3175PubMedCrossRef
10.
go back to reference Fleeetwood AJ, Cook AD, Hamilton JA (2005) Functions of granulocute-macrophage colony-stimulating factor. Crit Rev Immunol 25:405–428CrossRef Fleeetwood AJ, Cook AD, Hamilton JA (2005) Functions of granulocute-macrophage colony-stimulating factor. Crit Rev Immunol 25:405–428CrossRef
11.
go back to reference Minagawa H, Hashimoto K, Yanagi Y (2004) Absence of tumor necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections. J Gen Virol 85:343–347PubMedCrossRef Minagawa H, Hashimoto K, Yanagi Y (2004) Absence of tumor necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections. J Gen Virol 85:343–347PubMedCrossRef
12.
go back to reference Lundberg P, Welander PV, Edwards CK III, van Rooijen N, Cantin E (2007) Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2. J Virol 81:1452–1460CrossRef Lundberg P, Welander PV, Edwards CK III, van Rooijen N, Cantin E (2007) Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2. J Virol 81:1452–1460CrossRef
13.
go back to reference Theilgaard-Monch K, Porse BT, Borregaard N (2006) Systems biology of neutrophil differentiation and immune response. Curr Opin Immunol 18:54–60PubMedCrossRef Theilgaard-Monch K, Porse BT, Borregaard N (2006) Systems biology of neutrophil differentiation and immune response. Curr Opin Immunol 18:54–60PubMedCrossRef
14.
go back to reference Mistry SK, Zheng M, Rouse BT, Morris SM Jr (2001) Induction of arginases I and II in cornea during herpes simplex infection. Virus Res 73:177–182PubMedCrossRef Mistry SK, Zheng M, Rouse BT, Morris SM Jr (2001) Induction of arginases I and II in cornea during herpes simplex infection. Virus Res 73:177–182PubMedCrossRef
15.
go back to reference Niedbala W, Wei X, Campbell C, Thomson D, Komai-Koma M, Liew F (2002) Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor β2 expression via cGMP. ProNAS 99:16186–16191 Niedbala W, Wei X, Campbell C, Thomson D, Komai-Koma M, Liew F (2002) Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor β2 expression via cGMP. ProNAS 99:16186–16191
16.
go back to reference Molesworth-Kenyon SJ, Oakes JE, Lausch RN (2005) A novel role for neutrophils as a source of T cell-recruiting chemokines IP-10 and Mig during the DTH response to HSV-1 antigen. J Leukocyte Biol 77:552–559PubMedCrossRef Molesworth-Kenyon SJ, Oakes JE, Lausch RN (2005) A novel role for neutrophils as a source of T cell-recruiting chemokines IP-10 and Mig during the DTH response to HSV-1 antigen. J Leukocyte Biol 77:552–559PubMedCrossRef
Metadata
Title
Inhibition of HSV-1 by chemoattracted neutrophils: supernatants of corneal epithelial cells (HCE) and macrophages (THP-1) treated with virus components chemoattract neutrophils (PMN), and supernatants of PMN treated with these conditioned media inhibit viral growth
Authors
Kozaburo Hayashi
Laura C. Hooper
Toshiomi Okuno
Yuichiro Takada
John J. Hooks
Publication date
01-07-2012
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 7/2012
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-012-1306-y

Other articles of this Issue 7/2012

Archives of Virology 7/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.